oral semaglutide weight loss fda approves first-ever GLP-1RA for obesity and chronic management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda -approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight -loss-in-adults Article » PBD

An article published in the Journal of Physiological Anthropology found that those who clocked between 21.6 to 31.4km per week for at least six weeks before the study had significantly less body fat and visceral fat (the deep belly fat that surrounds your vital organs and is linked to cardiovascular diseases) than those who didnt hit the World Health Organisations guidelines of 150 minutes of moderate or 75 minutes of vigorous physical activity per week

Digital health integration is another emerging factor, with about 45% of GLP-1 Drug Market users leveraging mobile monitoring tools to track treatment outcomes

PMID 39413731

At the 9mg dose, the average was 26.4% still more than any prior drug has achieved